Imidazoles
- (1)
- (14)
- (30)
- (214)
- (3)
- (161)
- (4)
- (1)
- (1)
- (21)
- (1)
- (42)
- (7)
- (1)
- (186)
- (1)
- (200)
- (3)
- (18)
- (4)
- (3)
- (2)
- (10)
- (4)
- (2)
- (1)
- (6)
- (6)
- (4)
- (1)
- (5)
- (2)
- (5)
- (3)
- (2)
- (8)
- (2)
- (2)
- (4)
- (3)
- (5)
- (1)
- (2)
- (2)
- (1)
- (4)
- (2)
- (1)
- (2)
- (5)
- (1)
- (2)
- (3)
- (2)
- (3)
- (4)
- (4)
- (2)
- (4)
- (8)
- (8)
- (4)
- (3)
- (4)
- (3)
- (3)
- (3)
- (3)
- (3)
- (2)
- (1)
- (5)
- (4)
- (2)
- (4)
- (4)
- (4)
- (4)
- (2)
- (3)
- (5)
- (2)
- (5)
- (5)
- (3)
- (3)
- (4)
- (1)
- (1)
- (2)
- (3)
- (2)
- (5)
- (4)
- (3)
- (4)
- (1)
- (4)
- (2)
- (3)
- (4)
- (2)
- (3)
- (2)
- (5)
- (4)
- (4)
- (4)
- (3)
- (4)
- (3)
- (2)
- (4)
- (4)
- (1)
- (5)
- (4)
- (5)
- (3)
- (5)
- (3)
- (4)
- (3)
- (5)
- (2)
- (4)
- (4)
- (4)
- (4)
- (4)
- (5)
- (4)
- (3)
- (2)
- (4)
- (3)
- (5)
- (2)
- (3)
- (5)
- (5)
- (4)
- (5)
- (3)
- (1)
- (4)
- (2)
- (4)
- (5)
- (8)
- (4)
- (2)
- (4)
- (5)
- (1)
- (6)
- (3)
- (5)
- (4)
- (4)
- (1)
- (2)
- (2)
- (4)
- (4)
- (4)
- (2)
- (4)
- (5)
- (4)
- (4)
- (4)
- (3)
- (3)
- (8)
- (5)
- (2)
- (3)
- (5)
- (3)
- (5)
- (4)
- (2)
- (3)
- (1)
- (2)
- (4)
- (5)
- (4)
- (5)
- (3)
- (3)
- (2)
- (7)
- (5)
- (2)
- (2)
- (4)
- (4)
- (2)
- (3)
- (4)
- (4)
- (4)
- (4)
- (4)
- (7)
- (3)
- (3)
- (3)
- (4)
- (2)
- (5)
- (5)
- (3)
- (2)
- (4)
- (6)
- (3)
- (4)
- (4)
- (2)
- (5)
- (5)
- (2)
- (4)
- (4)
- (9)
- (4)
- (3)
- (6)
- (3)
- (5)
- (5)
- (3)
- (3)
- (1)
- (2)
- (4)
- (3)
- (5)
- (5)
- (5)
- (4)
- (3)
- (4)
- (4)
- (4)
- (2)
- (3)
- (3)
- (4)
- (4)
- (1)
- (1)
- (2)
- (1)
- (5)
- (5)
- (3)
- (7)
- (5)
- (3)
- (2)
- (5)
- (4)
- (4)
- (5)
- (1)
- (2)
- (3)
- (4)
- (4)
- (2)
- (2)
- (3)
- (2)
- (99)
- (801)
- (2)
- (897)
- (1)
- (40)
- (3)
- (4)
- (4)
- (2)
- (2)
- (2)
- (2)
- (4)
- (2)
- (5)
- (5)
- (5)
- (2)
- (2)
- (1)
- (4)
- (4)
- (5)
- (4)
- (4)
- (3)
- (4)
- (5)
- (1)
- (4)
- (3)
- (2)
- (4)
- (10)
- (5)
- (3)
- (4)
- (3)
- (2)
- (5)
- (146)
- (8)
- (15)
- (9)
- (3)
- (4)
- (2)
- (1)
- (10)
- (4)
- (5)
- (5)
- (2)
- (4)
- (2)
- (4)
- (4)
- (13)
- (6)
- (4)
- (2)
- (2)
- (9)
- (1)
- (5)
- (5)
- (4)
- (10)
- (5)
- (2)
- (4)
- (1)
- (3)
- (11)
- (7)
- (6)
- (4)
- (8)
- (8)
- (13)
- (5)
- (5)
- (7)
- (3)
- (9)
- (2)
- (5)
- (3)
- (2)
- (6)
- (4)
- (3)
- (3)
- (7)
- (6)
- (13)
- (8)
- (4)
- (7)
- (3)
- (3)
- (5)
- (3)
- (4)
- (3)
- (2)
- (11)
- (1)
- (4)
- (5)
- (4)
- (4)
- (4)
- (6)
- (4)
- (3)
- (9)
- (7)
- (5)
- (8)
- (3)
- (3)
- (4)
- (7)
- (2)
- (4)
- (5)
- (7)
- (7)
- (2)
- (3)
- (3)
- (4)
- (3)
- (3)
- (4)
- (5)
- (2)
- (8)
- (7)
- (3)
- (8)
- (9)
- (2)
- (3)
- (12)
- (5)
- (3)
- (5)
- (10)
- (7)
- (2)
- (4)
- (9)
- (2)
Filtered Search Results
1-Ethyl-3-methylimidazolium dicyanamide, 98%
CAS: 370865-89-7 Molecular Formula: C8H11N5 Molecular Weight (g/mol): 177.211 MDL Number: MFCD08276373 InChI Key: MKHFCTXNDRMIDR-UHFFFAOYSA-N Synonym: 1-ethyl-3-methylimidazolium dicyanamide,ethylmethylimidazolium dicyanamide,emim dca,acmc-209iqn,basionics™ vs 03,dsstox_cid_27940,dsstox_rid_82692,dsstox_gsid_47964,ksc221g0h PubChem CID: 11159638 IUPAC Name: cyanoiminomethylideneazanide;1-ethyl-3-methylimidazol-3-ium SMILES: CCN1C=C[N+](=C1)C.C(=[N-])=NC#N
| PubChem CID | 11159638 |
|---|---|
| CAS | 370865-89-7 |
| Molecular Weight (g/mol) | 177.211 |
| MDL Number | MFCD08276373 |
| SMILES | CCN1C=C[N+](=C1)C.C(=[N-])=NC#N |
| Synonym | 1-ethyl-3-methylimidazolium dicyanamide,ethylmethylimidazolium dicyanamide,emim dca,acmc-209iqn,basionics™ vs 03,dsstox_cid_27940,dsstox_rid_82692,dsstox_gsid_47964,ksc221g0h |
| IUPAC Name | cyanoiminomethylideneazanide;1-ethyl-3-methylimidazol-3-ium |
| InChI Key | MKHFCTXNDRMIDR-UHFFFAOYSA-N |
| Molecular Formula | C8H11N5 |
1-Methylimidazole, 99%
CAS: 616-47-7 Molecular Formula: C4H6N2 Molecular Weight (g/mol): 82.11 MDL Number: MFCD00005292 InChI Key: MCTWTZJPVLRJOU-UHFFFAOYSA-N Synonym: 1-methyl-1h-imidazole,n-methylimidazole,1h-imidazole, 1-methyl,imidazole, 1-methyl,n-methyl imidazole,1-methyl-imidazole,unii-p4617qs63y,1-methyl-1h-imidazol,n-methylimidazol,1-methylimdazole PubChem CID: 1390 ChEBI: CHEBI:113454 IUPAC Name: 1-methylimidazole SMILES: CN1C=CN=C1
| PubChem CID | 1390 |
|---|---|
| CAS | 616-47-7 |
| Molecular Weight (g/mol) | 82.11 |
| ChEBI | CHEBI:113454 |
| MDL Number | MFCD00005292 |
| SMILES | CN1C=CN=C1 |
| Synonym | 1-methyl-1h-imidazole,n-methylimidazole,1h-imidazole, 1-methyl,imidazole, 1-methyl,n-methyl imidazole,1-methyl-imidazole,unii-p4617qs63y,1-methyl-1h-imidazol,n-methylimidazol,1-methylimdazole |
| IUPAC Name | 1-methylimidazole |
| InChI Key | MCTWTZJPVLRJOU-UHFFFAOYSA-N |
| Molecular Formula | C4H6N2 |
Thermo Scientific Chemicals 1-Methylimidazole, for biochemistry, anhydrous, AcroSeal™
CAS: 616-47-7 Molecular Formula: C4H6N2 Molecular Weight (g/mol): 82.11 MDL Number: MFCD00005292 InChI Key: MCTWTZJPVLRJOU-UHFFFAOYSA-N IUPAC Name: 1-methyl-1H-imidazole SMILES: CN1C=CN=C1
| CAS | 616-47-7 |
|---|---|
| Molecular Weight (g/mol) | 82.11 |
| MDL Number | MFCD00005292 |
| SMILES | CN1C=CN=C1 |
| IUPAC Name | 1-methyl-1H-imidazole |
| InChI Key | MCTWTZJPVLRJOU-UHFFFAOYSA-N |
| Molecular Formula | C4H6N2 |
1,2-Dimethylimidazole, 96+%
CAS: 1739-84-0 Molecular Formula: C5H8N2 Molecular Weight (g/mol): 96.13 MDL Number: MFCD00005294 InChI Key: GIWQSPITLQVMSG-UHFFFAOYSA-N Synonym: 1,2-dimethyl-1h-imidazole,1h-imidazole, 1,2-dimethyl,imidazole, 1,2-dimethyl,1h-imidazole, dimethyl,unii-q41bc3grjb,q41bc3grjb,lupragen r dmi,1,2-dimethylimdazole,1,2 dimethylimidazole,n,2-dimethylimidazole PubChem CID: 15617 IUPAC Name: 1,2-dimethylimidazole SMILES: CN1C=CN=C1C
| PubChem CID | 15617 |
|---|---|
| CAS | 1739-84-0 |
| Molecular Weight (g/mol) | 96.13 |
| MDL Number | MFCD00005294 |
| SMILES | CN1C=CN=C1C |
| Synonym | 1,2-dimethyl-1h-imidazole,1h-imidazole, 1,2-dimethyl,imidazole, 1,2-dimethyl,1h-imidazole, dimethyl,unii-q41bc3grjb,q41bc3grjb,lupragen r dmi,1,2-dimethylimdazole,1,2 dimethylimidazole,n,2-dimethylimidazole |
| IUPAC Name | 1,2-dimethylimidazole |
| InChI Key | GIWQSPITLQVMSG-UHFFFAOYSA-N |
| Molecular Formula | C5H8N2 |
4-Nitroimidazole, 98%
CAS: 3034-38-6 Molecular Formula: C3H3N3O2 Molecular Weight (g/mol): 113.08 MDL Number: MFCD00005196 InChI Key: VYDWQPKRHOGLPA-UHFFFAOYSA-N Synonym: 4-nitroimidazole,4-nitro-1h-imidazole,1h-imidazole, 4-nitro,5-nitroimidazole,4 5-nitroimidazole,imidazole, 4-nitro,1h-imidazole, 5-nitro,unii-y8u32az5o7,5 4-nitroimidazole,4-nitro-3h-imidazole PubChem CID: 18208 ChEBI: CHEBI:64635 IUPAC Name: 5-nitro-1H-imidazole SMILES: [O-][N+](=O)C1=CN=CN1
| PubChem CID | 18208 |
|---|---|
| CAS | 3034-38-6 |
| Molecular Weight (g/mol) | 113.08 |
| ChEBI | CHEBI:64635 |
| MDL Number | MFCD00005196 |
| SMILES | [O-][N+](=O)C1=CN=CN1 |
| Synonym | 4-nitroimidazole,4-nitro-1h-imidazole,1h-imidazole, 4-nitro,5-nitroimidazole,4 5-nitroimidazole,imidazole, 4-nitro,1h-imidazole, 5-nitro,unii-y8u32az5o7,5 4-nitroimidazole,4-nitro-3h-imidazole |
| IUPAC Name | 5-nitro-1H-imidazole |
| InChI Key | VYDWQPKRHOGLPA-UHFFFAOYSA-N |
| Molecular Formula | C3H3N3O2 |
Tipifarnib, MedChemExpress
MedChemExpress Tipifarnib (IND 58359) binds to and inhibits farnesyltransferase (FTase) with an IC50 of 0.86 nM. Antineoplastic activity.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 489.4 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | Tipifarnib |
| Grade | Research |
| SMILES | O=C1N(C2=C(C(C3=CC=CC(Cl)=C3)=C1)C=C(C=C2)[C@@](N)(C4=CN=CN4C)C5=CC=C(C=C5)Cl)C |
| For Use With (Application) | Cancer-programmed cell death |
| Percent Purity | 96.64% |
| CAS | 192185-72-1 |
| Solubility Information | DMSO : 14.29 mg/mL (29.20 mM; Need ultrasonic) |
| Synonym | IND 58359 R115777 |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C27H22Cl2N4O |
| Formula Weight | 489.4 |
CVT-313, MedChemExpress
MedChemExpress CVT-313 (Cdk2 Inhibitor III) is a potent, selective, reversible, and ATP-competitive inhibitor of CDK2 with IC50 of 0.5 μM. CVT-313 inhibits CDC5L phosphorylation.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 400.47 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | CVT-313 |
| Grade | Research |
| SMILES | CC(N1C=NC2=C(NCC3=CC=C(OC)C=C3)N=C(N(CCO)CCO)N=C12)C |
| For Use With (Application) | Cancer-Kinase/protease |
| Percent Purity | 99.45% |
| CAS | 199986-75-9 |
| Solubility Information | DMSO : ≥ 100 mg/mL (249.71 mM) |
| Health Hazard 1 | H302 |
| Synonym | Cdk2 Inhibitor III |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C20H28N6O3 |
| Formula Weight | 400.47 |
GSK269962A, MedChemExpress
MedChemExpress GSK269962A (GSK 269962) is a potent ROCK inhibitor with IC50s of 1.6 and 4 nM for recombinant human ROCK1 and ROCK2 respectively. GSK269962A has anti-inflammatory and vasodilatory activities.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 570.6 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | GSK269962A |
| Grade | Research |
| SMILES | CCN1C2=CC(OC3=CC=CC(NC(C4=CC=C(OCCN5CCOCC5)C=C4)=O)=C3)=NC=C2N=C1C6=NON=C6N |
| For Use With (Application) | COVID-19-anti-virus |
| Percent Purity | 95.0% |
| CAS | 850664-21-0 |
| Solubility Information | DMSO : ≥ 30 mg/mL (52.58 mM) |
| Synonym | GSK 269962 |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C29H30N8O5 |
| Formula Weight | 570.6 |
CCT 137690, MedChemExpress
MedChemExpress CCT 137690 is a potent and orally available aurora kinase inhibitor with IC50s of 15, 25, and 19 nM for aurora A, B and C, respectively.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 551.48 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | CCT 137690 |
| Grade | Research |
| SMILES | CC1=CC(CN(CC2)CCN2C3=C4C(NC(C5=CC=C(N6CCN(C)CC6)C=C5)=N4)=NC=C3Br)=NO1 |
| For Use With (Application) | Cancer-Kinase/protease |
| Percent Purity | 99.1% |
| CAS | 1095382-05-0 |
| Solubility Information | DMSO : 16.67 mg/mL (30.23 mM; Need ultrasonic) |
| Health Hazard 1 | H317∣H319 |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C26H31BrN8O |
| Formula Weight | 551.48 |
IRAK inhibitor 2, MedChemExpress
MedChemExpress IRAK inhibitor 2 is interleukin-1 receptor associated kinase inhibitor .
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 306.32 |
|---|---|
| Color | Light Yellow |
| Physical Form | Solid |
| Chemical Name or Material | IRAK inhibitor 2 |
| Grade | Research |
| SMILES | OC1=CC=C(C=C1)C2=CN=C3C=CC(NCC4=CC=CO4)=NN32 |
| For Use With (Application) | COVID-19-immunoregulation |
| Percent Purity | 98.87% |
| CAS | 928333-30-6 |
| Solubility Information | DMSO : ≥ 50 mg/mL (163.23 mM) |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C17H14N4O2 |
| Formula Weight | 306.32 |
Purvalanol A, MedChemExpress
MedChemExpress Purvalanol A is a potent CDK inhibitor, which inhibits cdc2-cyclin B, cdk2-cyclin A, cdk2-cyclin E, cdk4-cyclin D1, and cdk5-p35 with IC50s of 4, 70, 35, 850, 75 nM, resepctively.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 388.89 |
|---|---|
| Color | Light Yellow |
| Physical Form | Solid |
| Chemical Name or Material | Purvalanol A |
| Grade | Research |
| SMILES | CC([C@@H](NC1=NC(NC2=CC=CC(Cl)=C2)=C3N=CN(C(C)C)C3=N1)CO)C |
| For Use With (Application) | Cancer-Kinase/protease |
| Percent Purity | 99.11% |
| CAS | 212844-53-6 |
| Solubility Information | DMSO : ≥ 50 mg/mL (128.57 mM) |
| Synonym | NG-60 |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C19H25ClN6O |
| Formula Weight | 388.89 |
BRD9539, MedChemExpress
MedChemExpress BRD9539 is a histone methyltransferase G9a inhibitor with an IC50 of 6.3 μM. BRD9539 also inhibits PRC2 activity and is inactive against SUV39H1, NSD2 and DNMT1.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 399.44 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | BRD9539 |
| Grade | Research |
| SMILES | O=C(C1=CC=C2C(N=C(NC(C3=CC=CC=C3)=O)N2CCCC4=CC=CC=C4)=C1)O |
| For Use With (Application) | Cancer-Kinase/protease |
| Percent Purity | 99.2% |
| CAS | 1374601-41-8 |
| Solubility Information | DMSO : 16.67 mg/mL (41.73 mM; Need ultrasonic) |
| Health Hazard 1 | H302 |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C24H21N3O3 |
| Formula Weight | 399.44 |
GSK-923295, MedChemExpress
MedChemExpress GSK-923295 is a special, allosteric inhibitor of centromere-associated protein-E (CENP-E) kinesin motor ATPase activity, with Ki of 3.2±0.2 nM and 1.6± 0.1 nM for human and canine, respectively.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 592.13 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | GSK-923295 |
| Grade | Research |
| SMILES | O=C(N[C@@H](CC1=CC=C(C2=CN3C(C([C@@H](O)C)=CC=C3)=N2)C=C1)CNC(CN(C)C)=O)C4=CC(Cl)=C(C=C4)OC(C)C |
| For Use With (Application) | Cancer-programmed cell death |
| Percent Purity | 98.08% |
| CAS | 1088965-37-0 |
| Solubility Information | DMSO : 30 mg/mL (50.66 mM; Need ultrasonic) |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C32H38ClN5O4 |
| Formula Weight | 592.13 |
Longdaysin, MedChemExpress
MedChemExpress Longdaysin is a inhibitor of the Wnt/β-catenin signaling pathway, which exerts antitumor effect through blocking CK1δ/ε-dependent Wnt signaling. Longdaysin inhibits CK1α, CK1δ, CDK7, and ERK2 with IC50s of 5.6 μM, 8.8 μM, 29 μM, and 52 μM, respectively.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 335.33 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | Longdaysin |
| Grade | Research |
| SMILES | FC(F)(F)C1=CC=CC(CNC2=NC=NC3=C2N=CN3C(C)C)=C1 |
| For Use With (Application) | Cancer-Kinase/protease |
| Percent Purity | 99.87% |
| CAS | 1353867-91-0 |
| Solubility Information | DMSO : 125 mg/mL (372.77 mM; Need ultrasonic) |
| Purity Grade Notes | Research |
| Recommended Storage | 4°C, protect from light∣In solvent : -80°C, 6 months∣-20°C, 1 month (protect from light) |
| Shelf Life | 4°C, protect from light∣In solvent : -80°C, 6 months∣-20°C, 1 month (protect from light) |
| Molecular Formula | C16H16F3N5 |
| Formula Weight | 335.33 |
9-Propenyladenine, MedChemExpress
MedChemExpress 9-Propenyladenine is a mutagenic impurity in tenofovir disoproxil fumarate. Tenofovir is an antiretroviral drug known as nucleotide analogue reverse transcriptase inhibitors, which block reverse transcriptase, a crucial virus enzyme in HIV-1 and HBV.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 175.19 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | 9-Propenyladenine |
| Grade | Research |
| SMILES | NC1=C2N=CN(/C=C/C)C2=NC=N1 |
| For Use With (Application) | COVID-19-anti-virus |
| Percent Purity | 96.69% |
| CAS | 1446486-33-4 |
| Solubility Information | DMSO : ≥ 29 mg/mL (165.53 mM) |
| Synonym | Mutagenic Impurity of Tenofovir Disoproxil Tenofovir Impurity 2 |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C8H9N5 |
| Formula Weight | 175.19 |